A detailed history of Bridgeway Capital Management, LLC transactions in Absci Corp stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 165,000 shares of ABSI stock, worth $508,200. This represents 0.02% of its overall portfolio holdings.

Number of Shares
165,000
Previous 270,500 39.0%
Holding current value
$508,200
Previous $1.14 Million 17.52%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$3.41 - $5.74 $359,755 - $605,570
-105,500 Reduced 39.0%
165,000 $937,000
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $21,275 - $88,615
18,500 Added 7.34%
270,500 $1.14 Million
Q3 2023

Nov 14, 2023

BUY
$1.28 - $2.41 $15,872 - $29,884
12,400 Added 5.18%
252,000 $332,000
Q2 2023

Aug 14, 2023

BUY
$1.17 - $2.03 $175,500 - $304,499
150,000 Added 167.41%
239,600 $364,000
Q1 2023

May 15, 2023

BUY
$1.58 - $3.41 $141,568 - $305,536
89,600 New
89,600 $156,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $286M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.